𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C in African Americans

✍ Scribed by Kerry N. Whitt; Jaquelyn F. Fleckenstein

Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
220 KB
Volume
7
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selective decrease in hepatitis C virus–
Selective decrease in hepatitis C virus–specific immunity among African Americans and outcome of antiviral therapy
✍ Hugo R. Rosen; Scott J. Weston; KyungAh Im; Huiying Yang; James R. Burton Jr.; H πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, end-stage liver disease, and hepatocellular carcinoma throughout the world. Considerable evidence indicates that the risk of viral persistence, natural history, and response to antiviral therapy varies among racial groups, bu

Impact of weight-based ribavirin with pe
Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1
✍ Ira M. Jacobson; Robert S. Brown Jr; Jonathan McCone; Martin Black; Clive Albert πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 313 KB πŸ‘ 1 views

Brass, 14 for the WIN-R Study Group WIN-R (Weight-based dosing of pegINterferon alfa-2b and Ribavirin) was a multicenter, randomized, open-label, investigator-initiated trial involving 236 community and academic sites in the United States, comparing response to pegylated interferon (PEG-IFN) alfa-2b